{"id":"NCT01254604","sponsor":"Merck Sharp & Dohme LLC","briefTitle":"Preservative-Free Tafluprost (MK-2452) for the Treatment of Open-Angle Glaucoma or Ocular Hypertension (MK-2452-002)","officialTitle":"A Phase III, Randomized, Active Comparator-Controlled, Four-Week, Double-Masked Clinical Trial to Compare the Efficacy and Safety of Preservative-Free MK-2452 (0.0015%) and Preservative-Free Timolol Maleate (0.5%) in Patients With Open-Angle Glaucoma or Ocular Hypertension in India","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2011-12-01","primaryCompletion":"2013-05-09","completion":"2013-05-09","firstPosted":"2010-12-06","resultsPosted":"2014-05-09","lastUpdate":"2018-09-20"},"enrollment":190,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Glaucoma","Ocular Hypertension"],"interventions":[{"type":"DRUG","name":"Preservative-Free Tafluprost or vehicle","otherNames":["MK-2452"]},{"type":"DRUG","name":"Preservative-Free Timolol maleate","otherNames":["Preservative-Free Timoptic"]}],"arms":[{"label":"Tafluprost","type":"EXPERIMENTAL"},{"label":"Timolol","type":"ACTIVE_COMPARATOR"}],"summary":"This study will test the hypothesis that preservative-free tafluprost (MK-2452) is non-inferior to preservative-free timolol maleate with respect to the diurnal intraocular pressure (IOP) change from baseline after 4 weeks of therapy in participants with open-angle glaucoma or ocular hypertension.","primaryOutcome":{"measure":"Mean Diurnal IOP Change From Baseline at Week 4 - Study Eye","timeFrame":"Baseline and Week 4","effectByArm":[{"arm":"Tafluprost","deltaMin":-8.3,"sd":null},{"arm":"Timolol","deltaMin":-6.6,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":null}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":8,"exclusionCount":11},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":["27292765"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":93},"commonTop":["Conjunctivitis","Eye irritation","Eye pruritus","Ocular hyperaemia"]}}